Jouko Yliruusi

Solubility Co. Ltd is a preclinical contract research organization that provides physicochemical measurement services using the proprietary SPA method. The company is based in an undisclosed location and their team is driven to success. The Finnish company's focus is on assisting early-stage decision-making by providing crucial information about substances in development. The company was founded in 2013 and is led by CEO Sami Svanbäck.

Solubility Co. Ltd is a preclinical contract research organization that provides physicochemical measurement services using the proprietary SPA method. The company is based in an undisclosed location and their team is driven to success. The Finnish company's focus is on assisting early-stage decision-making by providing crucial information about substances in development. The company was founded in 2013 and is led by CEO Sami Svanbäck.

Solubility Co. Ltd is a preclinical contract research organization that provides physicochemical measurement services using the proprietary SPA method. The company is based in an undisclosed location and their team is driven to success. The Finnish company's focus is on assisting early-stage decision-making by providing crucial information about substances in development. The company was founded in 2013 and is led by CEO Sami Svanbäck.

Solubility Co. Ltd is a preclinical contract research organization that provides physicochemical measurement services using the proprietary SPA method. The company is based in an undisclosed location and their team is driven to success. The Finnish company's focus is on assisting early-stage decision-making by providing crucial information about substances in development. The company was founded in 2013 and is led by CEO Sami Svanbäck.

Solubility Co. Ltd is a preclinical contract research organization that provides physicochemical measurement services using the proprietary SPA method. The company is based in an undisclosed location and their team is driven to success. The Finnish company's focus is on assisting early-stage decision-making by providing crucial information about substances in development. The company was founded in 2013 and is led by CEO Sami Svanbäck.